GeneGlobe ID: PHS-003Z | Cat. No.: | QIAseq Targeted DNA Pro Panels

QIAseq Targeted DNA Pro Human Myeloid Neoplasms Research Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Leukemia
Acute Lymphoblastic Leukemia (ALL)​
ABL1, ABL2 (ARG), BIRC3 (c-IAP2), BRAF, BTK, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CREBBP (CBP), CRLF2 (TSLPR), EBF1, EP300, ETV6, FBXW7, FLT3, GATA3, HRAS, IKZF1, IL7R, JAK1, JAK2, JAK3, KDM6A, KMT2A, KRAS, MYC, NOTCH1, NRAS, PAX5, PDGFRB, PLCG2, PTEN, PTPN11, RUNX1 (AML1), SF3B1, SH2B3, TP53 (p53)
Acute Myeloid Leukemia (AML)​
ANKRD26, ASXL1, ATRX, BRCA1, BRCA2, CBFB, CBLB, CBLC, CCND2, CDC25C, CEBPA, CUX1, DCK, DDX41, DHX15, DNMT3A, ELANE, ETV6, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, IKZF2, IKZF3, JAK2, KDM6A, KIT (CD117), KMT2A, KRAS, LUC7L2, MTOR, NPM1, NRAS, NUP214, PDGFRA, PICALM, PRPF8, PTPN11, RB1, RBBP6, RPS14, RUNX1 (AML1), SF3B1, SLC29A1, SMC1A, TERT, TET1, TET2, TP53 (p53), U2AF1, U2AF2, WT1, ZEB2
Acute Promyelocytic Leukemia (APML; APL)​
CEBPA, NPM1, NUMA1, RARA, RUNX1 (AML1)
Atypical Chronic Myeloid Leukemia (aCML)​
ASXL1, CBL, CEBPA, EZH2, FLT3, JAK2, KRAS, NPM1, NRAS, RUNX1 (AML1), SETBP1, SRSF2, TET2, U2AF1
Chronic Lymphocytic Leukemia (CLL)​
ATRX, BCL2, BIRC3 (c-IAP2), BRAF, CBLB, CCND2, CD38, CUX1, GNAS, GNB1, LUC7L2, MYD88, NOTCH1, NRAS, PTPN11, SF3B1, TP53 (p53), U2AF2, XPO1, ZAP70
Chronic Myeloid Leukemia (CML)​
ABL1, ASXL1, BCOR, BCR, BRAF, CBL, CREBBP (CBP), DNMT3A, DNMT3B, EZH2, IDH1, IDH2, IKZF1, JAK2, KRAS, NPM1, NRAS, RUNX1 (AML1), TET1, TET2, TP53 (p53), WT1
Chronic Myelomonocytic Leukemia (CMML)​
ASXL1, BCOR, BCORL1, CBL, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KIT (CD117), KRAS, MPL, NF1, NPM1, NRAS, PHF6, PTPN11, RUNX1 (AML1), SETBP1, SF3B1, SRSF2, STAG2, TET2, TP53 (p53), U2AF1, ZRSR2
Hairy Cell Leukemia​
BRAF, CDKN1B (P27KIP1), MAP2K1, TP53 (p53)
Juvenile Myelomonocytic Leukemia​
ARHGAP26, CBL, KRAS, NRAS, PTPN11
Lymphomas
Acute Lymphocytic Lymphomas​
BIRC3 (c-IAP2), BTK, CDKN2A (P16INK4A), CDKN2B (p15INK4b), MYC, NOTCH1, PLCG2, SF3B1, TP53 (p53)
B Cell Lymphomas​
BCL6, BRAF, CD79A, CHEK2 (RAD53), EZH2, MAP2K1, MYD88, STAT6, TNFRSF14, TP53 (p53)
Burkitt Lymphomas​
CBLB, GNA13, H1-4, MTOR, MYC
Diffuse Large B Cell Lymphomas​
B2M, BCL2, CBLB, GNA13, H1-4, KMT2D, MTOR, PIM1, PRPF8, SOCS1, TNFAIP3
Follicular Lymphomas​
ARID1A, BCL10, BCL2, CARD11, CREBBP (CBP), EP300, EZH2, FOXO1, KMT2D, MEF2B
Mantle Cell Lymphomas​
ATM, CCND1
Marginal Zone Lymphomas​
KLF2, MYD88, NOTCH2, TNFAIP3, TP53 (p53)
Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas​
BCL10, TNFAIP3
Non-Hodgkin Lymphomas​
BRAF, CASP10 (MCH4), NRAS, PIK3CA (p110-alpha), RAD54B, RAD54L, TP53 (p53)
Primary Cutaneous Lymphomas​
CD79B, MYD88
Small Lymphocytic Lymphomas​
ATRX, BCL2, CBLB, CCND2, CUX1, GNAS, LUC7L2, U2AF2, XPO1
T Cell Lymphomas​
ARID1B, ATM, CBLB, CCR4, DNMT3A, IDH1, IDH2, INO80, JAK1, JAK3, RHOA, SETD2, STAT3, STAT5B, TET2
Myelodysplastic Syndromes & Myeloproliferative Neoplasms
Myelodysplastic Syndromes​
ANKRD26, ASXL1, ATRX, BCOR, BCORL1, CALR, CBL, CEBPA, CSF3R (GM-CSFR), CUX1, DDX41, DKC1, DNMT3A, ETNK1, ETV6, EZH2, FLT3, GATA2, GNAS, GNB1, IDH1, IDH2, JAK2, JAK3, KIT (CD117), KRAS, MPL, NF1, NPM1, NRAS, PHF6, PIGA, PPM1D, PTPN11, RAD21, RUNX1 (AML1), SAMD9, SAMD9L, SETBP1, SF3B1, SMC3, SRP72, SRSF2, STAG2, STAT3, TERC, TERT, TET2, TP53 (p53), U2AF1, WT1, ZRSR2
Myeloproliferative Neoplasms​
ASXL1, BCOR, CALR, CBL, CSF3R (GM-CSFR), DNMT3A, ETV6, EZH2, IDH1, IDH2, JAK2, KIT (CD117), MPL, NOTCH1, NRAS, PDGFRA, RUNX1 (AML1), SETBP1, SF3B1, SH2B3, SRSF2, STAT3, STAT5B, TET2, TP53 (p53), U2AF1, ZRSR2
Other Myeloid Neoplasms
Essential Thrombocythemia​
ASXL1, CBL, IDH2, JAK2, MPL, SF3B1, TET2, TP53 (p53)
Multiple Myeloma​
ATM, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CHEK1, CHEK2 (RAD53), CXCR4, EGFR (ERBB1), ERBB2 (HER-2, NEU), FANCL, FGFR3, IDH1, IDH2, KIT (CD117), KRAS, MET, NRAS, PALB2, PDGFRA, RAD51B, RAD51C, RAD51D, RET, TP53 (p53)
Plasma Cell Myeloma​
HRAS, MTOR, RB1, SLC29A1
Polycythemia Vera​
ASXL1, DNMT3A, EZH2, IDH1, JAK2, NRAS, TET2, TP53 (p53)
Primary Myelofibrosis​
ASXL1, CBL, DNMT3A, EZH2, IDH1, IDH2, JAK2, MPL, NF1, NRAS, SETBP1, SF3B1, SRSF2, TET2, TP53 (p53)
Systemic Mastocytosis​
ASXL1, CBL, DNMT3A, ETV6, EZH2, IDH2, JAK2, KIT (CD117), KRAS, NPM1, NRAS, RUNX1 (AML1), SETBP1, SF3B1, SRSF2, TET2, TPSAB1, U2AF1
Waldenstrom Macroglobulinemia​
CXCR4, MYD88

Resources

Application Notes (1)
Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing of DNA for Ion Torrent NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Template Files (1)
icon_0071_person-s

Do you want to create a custom panel or to boost an existing one?

 

Introducing the QIAseq Targeted DNA Pro Human Myeloid Neoplasms Research Panel, a cutting-edge addition to our QIAseq Targeted DNA Pro Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted DNA Pro Human Myeloid Neoplasms Research Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted DNA Pro Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted DNA Pro Human Myeloid Neoplasms Research Panel and elevate your work to new heights.